Rectal cancer

This study is comparing a SPECT CT scan with DCE MRI scans and tissue sample results to measure new cancer blood vessel growth in people with cancer.

A trial of methotrexate for cancer that has spread in people with a change to a gene called MSH2.

This trial looked at capecitabine (Xeloda) and oxaliplatin (Eloxatin) chemotherapy or no chemotherapy after surgery for rectal cancer.

This trial is looking at removing the original (primary) area of cancer in the bowel or back passage before chemotherapy.

This trial compared conventional surgery with keyhole surgery for bowel cancer, when both types of surgery were carried out alongside ways to improve recovery.

This study looked at symptoms people might have that show bowel cancer is coming back after surgery.

This trial is looking at a drug called dalotuzumab alongside irinotecan for cancer of the back passage (rectum) that has spread to other parts of the body.

This trial is looking at a drug called etirinotecan pegol for bowel cancer that has spread to other parts of the body.

This trial was looking at continuous or intermittent cetuximab alongside chemotherapy for bowel cancer that has spread (advanced bowel cancer).

This trial looked at irinotecan alone, irinotecan with panitumumab or irinotecan with ciclosporin for bowel cancer.